dexmedetomidine.
Conditions
Interventions
Intervention 1: Intervention group: Dexmedetomidine , 0.1 mcg/kg/min, once at the beginning of surgery, intraoperative infusion. Intervention 2: Control group: Normal saline serum, 0.1 mcg/kg/min, rec
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: patients undergoing discopathy surgery
Exclusion criteria
Exclusion criteria: dibetic person endocrine disorders cardiovascular disease liver disorders kidney disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of dexmedetomidine drug on blood sugar of people undergoing discopathy surgery. Timepoint: before the start of the intervention and 10, 30, and 60 minutes after the operation and 10 minutes after the operation. Method of measurement: glucometr. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood sugar. Timepoint: at the beginning of the study and at 10, 30, 60 and 10 minutes after the end of the surgery. Method of measurement: glucometr.;BMI. Timepoint: Before surgery. Method of measurement: Based on the body mass index formula.;Pain level of patients after surgery. Timepoint: after surgery. Method of measurement: Visual Analogue Scale.;Hemodynamic. Timepoint: Before the intervention, during the operation and after the operation. Method of measurement: Measuring blood pressure with a sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactali ghomeishi
Ahvaz University of Medical Sciences
Outcome results
None listed